According to the company, the results reflect the broader economic headwinds affecting Egypt’s food and grain processing sector.
Sales for the period ending March 31, 2025, also saw robust growth, climbing 21% year-on-year to EGP 599.979 million (US$ 19.4 million).
The company’s authorized capital will remain unchanged at US$7 million, while the issued capital will double, increasing the number of shares to 1,400,027,312, each with a nominal value of EGP 0.20 (US$0.004).
The group has received the U.S. Food and Drug Administration (FDA) certification, which is essential for entering the highly regulated U.S. market.
Total wheat consumption in 2025-26 is expected to reach 20.4 million tonnes, which would be up nearly 1.5% from 2024-25.